Today the U.S. House of Representatives passed the Inflation Reduction Act, which includes several provisions that will reduce the costs of health care for millions of cancer patients and survivors.
Today the U.S. Senate passed the Inflation Reduction Act, which includes several provisions that will reduce the costs of health care for millions of cancer patients and survivors.
Congress reached a significant budget deal that includes key provisions that will improve affordability of health care coverage for many cancer patients, survivors and their loved ones.
The Health and Human Services Department released a proposed rule Monday expanding nondiscrimination protections for patients using federally funded health programs.
Albany, NY – A new Survivor Views survey from the American Cancer Society Cancer Action Network (ACS CAN) shows that while copay assistance programs can help cancer patients afford the medications they need, some aren’t able
A new national poll conducted by a bipartisan team of researchers for ACS CAN found 8 in 10 (81%) voters agree that the government should protect people so that they don’t lose their coverage during high inflation and economic instability.
The Centers for Medicare and Medicaid Services (CMS) released proposed changes to the 2023 Medicare program that, if finalized, would eliminate cost sharing for colonoscopies after a positive non-invasive screening test, and lower the minimum age of colorectal cancer screening to 45.
RALEIGH, NC – July 1, 2022 – Today, the North Carolina General Assembly completed its short session and left Raleigh with the matter of Medicaid expansion unresolved, meaning that 600,000 hard-working, woul
Today, the North Carolina General Assembly completed its short session and left Raleigh with the matter of Medicaid expansion unresolved, meaning that 600,000 hard-working, would-be eligible North Carolinians are forced to wait even longer for a chance at affordable access to care.
As a nonprofit entity whose mission is improving the lives of people with cancer and their families, the American Cancer Society isn’t taking sides on the decision. However, the decision will impact cancer patients and their families and is likely to disproportionately effect communities of color.